Founder & Chief Strategy Officer, Cure Forward
Martin Naley is the founder and CEO of Cure Forward, a company that spans digital health, genomics, and social media, to make personalized medicine accessible and practically useful for patients. The company is being incubated by Apple Tree Partners, where Martin has been an Entrepreneur-in-Residence. Prior to joining Apple Tree Partners, Martin held many roles over a span of 15 years at Life Technologies, from sales rep to CEO Chief of Staff, where he worked with partners to develop some of the first NGS-based diagnostic tests and shaped a worldwide network for genomic data sharing. Mr. Naley holds a B.A. in Biological Sciences from Cornell and an M.B.A. from Yale.
Session: Impact of Patient Data Access on Oncology Precision Medicine
Individual consumers can engage in science and drive new therapies forward. In fact, we can’t do it without them. Through current regulations, patients have the legal right to their test data, but what can they do with it? In this session, we will hear how individuals, when armed with the scientific information underpinning their disease, can positively impact their own care and also advance precision medicine for others.